Prosthetic Heart Valves Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Prosthetic Heart Valves Market Report Overview
The prosthetic heart valves market size was valued at $2.10 billion in 2022. The increase in aging population across the globe and the associated valvular degeneration is a major driving factor of the Prosthetic Heart Valve market. The prevalence of valvular heart diseases increases with age. Globally over 100 million people are affected by Valvular Heart Diseases including cases Valve Stenosis and Regurgitation.
Prosthetic Heart Valves Market Outlook, 2022-2033 ($ Billion)
For more insights into the prosthetic heart valves market forecast, download a free report sample
The report is built to visualize quantitative market trends within cardiovascular devices therapeutic areas. The model discusses in detail the impact of COVID-19 on the Prosthetic heart valves market for the year 2020 and beyond. Each of the covered 39 country’s color-coded and fully sourced market models is equipped with epidemiology-based indications with procedure volumes.
Market Size (2022) | $2.10 billion |
Forecast Period | 2023-2033 |
Historical Period | 2015-2022 |
Key Regions | · North America
· Europe · Asia Pacific · South Central America · Middle East and Africa |
Key Segments | · Mechanical Heart Valves
· Tissue Heart Valves |
Leading Companies | · Edwards Lifesciences Corp
· Abbott Laboratories · Medtronic Plc · Corcym UK Ltd · Artivion Inc · Lepu Medical Technology (Beijing) Co Ltd · TTK Healthcare Ltd · Braile Biomedica Ltda · Others |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Prosthetic Heart Valves Market Dynamics
With the increasing burden of an aging population, and an increase in the associated valvular diseases, especially aortic valve stenosis, there is an increasing demand for tissue valve replacements. While the development of devices like TAVR has made a negative impact on the surgical prosthetic heart valve market, the high cost of TAVR and the expertise required to perform the procedure has limited this impact. Also, the availability of minimally invasive alternatives to TAVR in the form of tissue sutureless aortic valves has bolstered the Tissue Heart Valves market. Furthermore, due to the success of the tissue sutureless aortic valve, there is a growing interest in tissue sutureless mitral valves. In 2013, a preclinical study was completed that analyzed the feasibility of this device; however, the long-term stability of the device is still to be studied and it will take several years for the device to move from preclinical trials to clinical trials phase.
Prosthetic Heart Valves Market Segments
The Prosthetic heart valves market comprises key segments including Mechanical Heart Valves and Tissue Heart Valves. In 2022, the Tissue Heart Valves segment dominated the prosthetic heart valves market share. Thrombectomy devices can be further segmented into four categories including Tissue Sutured Aortic Valve Replacements, Tissue Sutured Mitral Valve Replacements, and Tissue Sutureless Aortic Valve Replacements
Prosthetic Heart Valves Market Analysis by Segments, 2022 (%)
For more insights into the prosthetic heart valves market segments, download a free report sample
Prosthetic Heart Valves Market Segmentation by Regions
The key regions in the prosthetic heart valves market are North America, Europe, Asia Pacific, South Central America, and the Middle East and Africa. North America has the largest share of the prosthetic heart valves market. The US, Canada, and Mexico will experience growth in their number of Prosthetic Heart Valve replacements, during the forecast period. These changes are expected to align with trends in aging population and associated degenerative valvular conditions.
The increasing usage of Transcatheter Aortic Valve Replacement and declining incidence of rheumatic fever will slow the overall growth, however the increase in the usage of tissue valves, especially tissue sutureless aortic valves, will drive the market.
Prosthetic Heart Valves Market Analysis by Regions, 2022 (%)
For more insights into the prosthetic heart valves market segments, download a free report sample
Prosthetic Heart Valves Market - Competitive Landscape
Some of the leading companies in the prosthetic heart valves market are Edwards Lifesciences Corp, Abbott Laboratories, Medtronic Plc, Corcym UK Ltd, Artivion Inc, Lepu Medical Technology (Beijing) Co Ltd, TTK Healthcare Ltd, and Braile Biomedica Ltda among others. Edwards Lifesciences Corp held the largest share of the prosthetic heart valves market in 2022.
Prosthetic Heart Valves Market Analysis by Companies, 2022 (%)
To know more about the leading companies in the prosthetic heart valves market, download a free report sample
Segments Covered in the Report
Prosthetic Heart Valves Segments Outlook (Value, $ Million, 2015-2033)
- Mechanical Heart Valves
- Mechanical Sutured Aortic Valve Replacements
- Mechanical Sutured Mitral Valve Replacements
- Tissue Heart Valves
- Tissue Sutured Aortic Valve Replacements
- Tissue Sutured Mitral Valve Replacements
- Tissue Sutureless Aortic Valve Replacements
Prosthetic Heart Valves Regional Outlook (Value, $ Million, 2015-2033)
- North America
- Europe
- Asia Pacific
- South Central America
- Middle East and Africa
Key Inclusions of the market model are –
- Currently marketed Prosthetic heart valves market and evolving competitive landscape
- Insightful review of the key industry trends.
- Annualized total Prosthetic heart valves market revenue by segment and market outlooks from 2015-2033.
- Granular data on total procedures, units, average selling prices, and market values by segment.
Global, Regional, and Country level market specific insights –
- Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the Prosthetic heart valves market.
- Competitive dynamics insights and trends provided Prosthetic heart valves market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Edwards Lifesciences Corp, Abbott Laboratories, Medtronic Plc, Corcym UK Ltd, Artivion Inc, Lepu Medical Technology (Beijing) Co Ltd, TTK Healthcare Ltd, Braile Biomedica Ltda, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
Scope
This report provides:
- Currently marketed prosthetic heart valves and evolving competitive landscape.
- Insightful review of the key industry trends.
- Annualized total prosthetic heart valves market revenue by segment and market outlooks.
- Granular data on total procedures, units, average selling prices, and market values by segment.
- Global, regional, and country-level market-specific insights.
- Qualitative market-specific information with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the prosthetic heart valves market.
- Competitive dynamics insights and trends provided for the prosthetic heart valves market.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific MedTech regulatory landscape.
Reasons to Buy
The model will enable you to –
- Understand the impact of COVID-19 on the prosthetic heart valves market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Prosthetic heart valves market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the prosthetic heart valves market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Track device sales in the global and country-specific prosthetic heart valves market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Abbott Laboratories
Medtronic plc
Corcym UK Ltd
Artivion Inc
Lepu Medical Technology (Beijing) Co Ltd
TTK Healthcare Ltd
Braile Biomedica Ltda
Others
Frequently asked questions
-
What was the prosthetic heart valves market size in 2022?
The prosthetic heart valves market size was valued at $2.10 billion in 2022.
-
Which region held the largest share of the prosthetic heart valves market?
North America held the largest prosthetic heart valves market share in 2022.
-
Which segment held the largest share of the prosthetic heart valves market?
Tissue Heart Valves led the prosthetic heart valves market in 2022.
-
Which are the major companies operating in the prosthetic heart valves market?
Some of the leading companies in the prosthetic heart valves market are Edwards Lifesciences Corp, Abbott Laboratories, Medtronic Plc, Corcym UK Ltd, Artivion Inc, Lepu Medical Technology (Beijing) Co Ltd, TTK Healthcare Ltd, and Braile Biomedica Ltda.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.